Cargando…
Coccidioidomycosis Skin Testing in a Commercially Insured Population, United States, 2014–2017
Coccidioidomycosis skin testing appears to be uncommon, based on US health insurance claims data. Patient demographic features were consistent with the approval of the test for adults, but few patients had previous coccidioidomycosis diagnosis codes supporting its use for detecting delayed-type hype...
Autores principales: | Benedict, Kaitlin, McCotter, Orion Z., Jackson, Brendan R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045843/ https://www.ncbi.nlm.nih.gov/pubmed/32091378 http://dx.doi.org/10.3201/eid2603.190798 |
Ejemplares similares
-
Coccidioidomycosis Outbreaks, United States and Worldwide, 1940–2015
por: Freedman, Michael, et al.
Publicado: (2018) -
Surveillance for Coccidioidomycosis — United States, 2011–2017
por: Benedict, Kaitlin, et al.
Publicado: (2019) -
Assessment of Vulnerability to Coccidioidomycosis in Arizona and California
por: Shriber, Jennifer, et al.
Publicado: (2017) -
Notes from the Field: Increase in Coccidioidomycosis — California, 2016
por: Cooksey, Gail Sondermeyer, et al.
Publicado: (2017) -
Sporotrichosis Cases in Commercial Insurance Data, United States, 2012–2018
por: Benedict, Kaitlin, et al.
Publicado: (2020)